Concepts (230)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain Injuries | 11 | 2023 | 2025 | 1.600 |
Why?
|
Brain Concussion | 6 | 2023 | 1320 | 1.320 |
Why?
|
Decompressive Craniectomy | 2 | 2022 | 72 | 0.970 |
Why?
|
Mannitol | 2 | 2022 | 181 | 0.880 |
Why?
|
Cerebrovascular Trauma | 1 | 2022 | 23 | 0.870 |
Why?
|
Vasospasm, Intracranial | 3 | 2021 | 208 | 0.820 |
Why?
|
Football | 2 | 2023 | 460 | 0.770 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2022 | 113 | 0.770 |
Why?
|
Coma | 2 | 2021 | 475 | 0.760 |
Why?
|
Hematoma, Subdural | 1 | 2021 | 126 | 0.760 |
Why?
|
Diffuse Axonal Injury | 2 | 2017 | 49 | 0.740 |
Why?
|
Diuretics, Osmotic | 1 | 2019 | 37 | 0.710 |
Why?
|
Moyamoya Disease | 2 | 2021 | 238 | 0.680 |
Why?
|
Saline Solution, Hypertonic | 1 | 2019 | 110 | 0.680 |
Why?
|
Vascular System Injuries | 1 | 2022 | 250 | 0.670 |
Why?
|
Brain Stem Hemorrhage, Traumatic | 1 | 2017 | 13 | 0.620 |
Why?
|
Tauopathies | 1 | 2021 | 307 | 0.590 |
Why?
|
Spinal Cord Injuries | 1 | 2024 | 931 | 0.540 |
Why?
|
Edema | 2 | 2020 | 789 | 0.510 |
Why?
|
Electric Injuries | 1 | 2014 | 26 | 0.500 |
Why?
|
Injury Severity Score | 4 | 2023 | 1014 | 0.440 |
Why?
|
Brain Stem | 1 | 2017 | 846 | 0.420 |
Why?
|
Neurology | 2 | 2018 | 763 | 0.420 |
Why?
|
Lung Diseases | 1 | 2022 | 1886 | 0.400 |
Why?
|
tau Proteins | 1 | 2021 | 1868 | 0.390 |
Why?
|
Optic Nerve Diseases | 1 | 2014 | 327 | 0.380 |
Why?
|
Cerebral Hemorrhage | 2 | 2020 | 2647 | 0.370 |
Why?
|
Status Epilepticus | 3 | 2023 | 444 | 0.360 |
Why?
|
Encephalitis, Herpes Simplex | 2 | 2023 | 60 | 0.350 |
Why?
|
Methylprednisolone | 3 | 2024 | 387 | 0.350 |
Why?
|
Chronic Disease | 2 | 2022 | 9146 | 0.340 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1671 | 0.340 |
Why?
|
Withholding Treatment | 1 | 2013 | 599 | 0.340 |
Why?
|
Intracranial Hemorrhages | 3 | 2021 | 855 | 0.340 |
Why?
|
Corpus Callosum | 3 | 2019 | 737 | 0.320 |
Why?
|
Heart-Assist Devices | 1 | 2018 | 1194 | 0.310 |
Why?
|
Brain Ischemia | 2 | 2021 | 3265 | 0.310 |
Why?
|
Critical Care | 2 | 2018 | 2647 | 0.300 |
Why?
|
Stroke | 3 | 2020 | 9981 | 0.300 |
Why?
|
Dementia | 1 | 2021 | 2518 | 0.300 |
Why?
|
Brain | 5 | 2021 | 26385 | 0.300 |
Why?
|
Mental Disorders | 2 | 2022 | 6600 | 0.260 |
Why?
|
Curriculum | 1 | 2017 | 3605 | 0.230 |
Why?
|
Intensive Care Units | 3 | 2021 | 3679 | 0.220 |
Why?
|
Subarachnoid Hemorrhage | 3 | 2021 | 1018 | 0.210 |
Why?
|
Humans | 50 | 2024 | 744343 | 0.200 |
Why?
|
Hypertension | 1 | 2022 | 8480 | 0.200 |
Why?
|
Anterior Temporal Lobectomy | 2 | 2023 | 48 | 0.200 |
Why?
|
Severity of Illness Index | 3 | 2020 | 15540 | 0.200 |
Why?
|
Muscle Weakness | 2 | 2015 | 413 | 0.190 |
Why?
|
Electrolytes | 1 | 2022 | 282 | 0.190 |
Why?
|
Mannose-Binding Lectin | 1 | 2022 | 150 | 0.190 |
Why?
|
Cardiovascular Diseases | 2 | 2023 | 15165 | 0.180 |
Why?
|
Prognosis | 6 | 2023 | 29063 | 0.180 |
Why?
|
Middle Aged | 24 | 2023 | 213383 | 0.180 |
Why?
|
Cerebral Hemorrhage, Traumatic | 1 | 2019 | 20 | 0.180 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2020 | 143 | 0.180 |
Why?
|
Intracranial Thrombosis | 1 | 2020 | 113 | 0.170 |
Why?
|
Cerebral Revascularization | 1 | 2021 | 238 | 0.170 |
Why?
|
Drainage | 2 | 2023 | 1142 | 0.170 |
Why?
|
Inflammation | 4 | 2020 | 10638 | 0.170 |
Why?
|
Retrospective Studies | 11 | 2023 | 77449 | 0.160 |
Why?
|
Cerebrospinal Fluid | 1 | 2021 | 534 | 0.160 |
Why?
|
Male | 30 | 2023 | 350118 | 0.150 |
Why?
|
Hippocampus | 2 | 2021 | 3675 | 0.150 |
Why?
|
Amnesia | 1 | 2019 | 248 | 0.150 |
Why?
|
Receptors, Interleukin-1 | 1 | 2018 | 262 | 0.150 |
Why?
|
Adult | 21 | 2023 | 214055 | 0.150 |
Why?
|
Head Injuries, Penetrating | 1 | 2016 | 28 | 0.140 |
Why?
|
Health Occupations | 1 | 2018 | 224 | 0.140 |
Why?
|
Internship and Residency | 1 | 2017 | 5788 | 0.140 |
Why?
|
Comorbidity | 2 | 2021 | 10388 | 0.140 |
Why?
|
Quality of Life | 3 | 2024 | 12804 | 0.140 |
Why?
|
Necrosis | 1 | 2020 | 1643 | 0.140 |
Why?
|
International Normalized Ratio | 1 | 2018 | 367 | 0.140 |
Why?
|
Adolescent | 9 | 2022 | 85781 | 0.130 |
Why?
|
Glasgow Coma Scale | 4 | 2019 | 570 | 0.130 |
Why?
|
Diffusion Tensor Imaging | 2 | 2016 | 2305 | 0.130 |
Why?
|
Dantrolene | 1 | 2014 | 26 | 0.130 |
Why?
|
Antibodies, Monoclonal | 2 | 2023 | 9274 | 0.130 |
Why?
|
Glasgow Outcome Scale | 1 | 2014 | 109 | 0.120 |
Why?
|
Female | 25 | 2023 | 380194 | 0.120 |
Why?
|
Hydrocephalus | 1 | 2021 | 748 | 0.120 |
Why?
|
Paresis | 1 | 2015 | 179 | 0.120 |
Why?
|
Aged | 14 | 2021 | 163280 | 0.120 |
Why?
|
Brain Waves | 1 | 2018 | 401 | 0.120 |
Why?
|
Blood-Brain Barrier | 1 | 2020 | 1017 | 0.120 |
Why?
|
Muscle Relaxants, Central | 1 | 2014 | 86 | 0.120 |
Why?
|
Aphasia | 1 | 2015 | 179 | 0.120 |
Why?
|
Heart Failure | 1 | 2018 | 10900 | 0.120 |
Why?
|
Leukoaraiosis | 1 | 2014 | 120 | 0.110 |
Why?
|
Protein Kinases | 1 | 2020 | 1640 | 0.110 |
Why?
|
Microglia | 2 | 2018 | 1266 | 0.110 |
Why?
|
Olivary Nucleus | 1 | 2013 | 128 | 0.110 |
Why?
|
Athletic Injuries | 1 | 2023 | 1154 | 0.110 |
Why?
|
Cerebral Angiography | 1 | 2018 | 1285 | 0.110 |
Why?
|
Cerebrovascular Circulation | 1 | 2022 | 2731 | 0.110 |
Why?
|
Intracranial Aneurysm | 1 | 2021 | 1197 | 0.100 |
Why?
|
Young Adult | 9 | 2021 | 56430 | 0.100 |
Why?
|
Anesthesia, General | 1 | 2018 | 1171 | 0.100 |
Why?
|
Venous Thrombosis | 1 | 2020 | 1239 | 0.100 |
Why?
|
Administration, Intranasal | 2 | 2023 | 446 | 0.100 |
Why?
|
Prospective Studies | 5 | 2022 | 53288 | 0.090 |
Why?
|
Neuroprotective Agents | 2 | 2014 | 941 | 0.090 |
Why?
|
Hypnotics and Sedatives | 1 | 2018 | 1162 | 0.090 |
Why?
|
Acute Disease | 2 | 2018 | 7149 | 0.090 |
Why?
|
Immunotherapy, Adoptive | 1 | 2019 | 1270 | 0.090 |
Why?
|
Inpatients | 1 | 2022 | 2518 | 0.090 |
Why?
|
Organ Transplantation | 1 | 2020 | 1139 | 0.090 |
Why?
|
Longitudinal Studies | 3 | 2022 | 13989 | 0.090 |
Why?
|
Pneumonia | 1 | 2021 | 2133 | 0.090 |
Why?
|
Warfarin | 1 | 2018 | 1496 | 0.090 |
Why?
|
Neurodegenerative Diseases | 1 | 2018 | 1061 | 0.090 |
Why?
|
Ischemia | 1 | 2018 | 1907 | 0.090 |
Why?
|
Muscular Atrophy, Spinal | 1 | 2012 | 259 | 0.090 |
Why?
|
Postoperative Complications | 2 | 2021 | 15295 | 0.080 |
Why?
|
Nervous System Diseases | 1 | 2019 | 1622 | 0.080 |
Why?
|
Registries | 2 | 2021 | 8089 | 0.080 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39050 | 0.080 |
Why?
|
Immunosuppressive Agents | 1 | 2020 | 4149 | 0.070 |
Why?
|
Graft Rejection | 1 | 2020 | 4397 | 0.070 |
Why?
|
Disease Models, Animal | 3 | 2021 | 18029 | 0.070 |
Why?
|
Thrombocytopenia | 1 | 2014 | 1179 | 0.070 |
Why?
|
Aspirin | 1 | 2018 | 3282 | 0.070 |
Why?
|
Databases, Factual | 1 | 2021 | 7729 | 0.070 |
Why?
|
Diagnosis, Differential | 2 | 2018 | 12959 | 0.070 |
Why?
|
Mice | 6 | 2023 | 81183 | 0.070 |
Why?
|
Cohort Studies | 4 | 2021 | 40561 | 0.060 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2018 | 3068 | 0.060 |
Why?
|
Central Nervous System Neoplasms | 1 | 2013 | 895 | 0.060 |
Why?
|
Hospital Mortality | 2 | 2020 | 5317 | 0.060 |
Why?
|
Lymphoma | 1 | 2013 | 1877 | 0.060 |
Why?
|
Risk Factors | 3 | 2021 | 72290 | 0.060 |
Why?
|
Animals | 9 | 2023 | 168757 | 0.060 |
Why?
|
Incidence | 2 | 2020 | 20947 | 0.060 |
Why?
|
Anticoagulants | 1 | 2018 | 4599 | 0.050 |
Why?
|
Trauma Centers | 2 | 2019 | 890 | 0.050 |
Why?
|
Acyclovir | 1 | 2023 | 272 | 0.050 |
Why?
|
Osmolar Concentration | 1 | 2022 | 683 | 0.050 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2023 | 342 | 0.050 |
Why?
|
rho-Associated Kinases | 1 | 2023 | 279 | 0.050 |
Why?
|
Water-Electrolyte Balance | 1 | 2022 | 346 | 0.050 |
Why?
|
Milrinone | 1 | 2021 | 84 | 0.050 |
Why?
|
Recovery of Function | 2 | 2021 | 2925 | 0.050 |
Why?
|
Cerebrospinal Fluid Shunts | 1 | 2021 | 189 | 0.040 |
Why?
|
Cerebral Veins | 1 | 2020 | 156 | 0.040 |
Why?
|
Consciousness Disorders | 1 | 2023 | 418 | 0.040 |
Why?
|
C-Reactive Protein | 2 | 2021 | 3778 | 0.040 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2023 | 644 | 0.040 |
Why?
|
Cell Membrane Permeability | 1 | 2020 | 590 | 0.040 |
Why?
|
GTP-Binding Proteins | 1 | 2023 | 970 | 0.040 |
Why?
|
Hyperkinesis | 1 | 2018 | 89 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2021 | 57776 | 0.040 |
Why?
|
Age Factors | 3 | 2021 | 18370 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 3 | 2021 | 35421 | 0.040 |
Why?
|
Interleukin-18 | 1 | 2018 | 249 | 0.040 |
Why?
|
Consciousness | 1 | 2022 | 572 | 0.040 |
Why?
|
Maze Learning | 1 | 2018 | 478 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2021 | 1677 | 0.030 |
Why?
|
Arousal | 1 | 2021 | 1165 | 0.030 |
Why?
|
Immunity | 1 | 2021 | 1012 | 0.030 |
Why?
|
Athletes | 1 | 2023 | 1093 | 0.030 |
Why?
|
T-Lymphocyte Subsets | 1 | 2023 | 1838 | 0.030 |
Why?
|
Immunocompromised Host | 1 | 2020 | 847 | 0.030 |
Why?
|
Models, Immunological | 1 | 2017 | 527 | 0.030 |
Why?
|
Disability Evaluation | 1 | 2022 | 1827 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2020 | 14557 | 0.030 |
Why?
|
Outpatients | 1 | 2021 | 1486 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2023 | 21827 | 0.030 |
Why?
|
Riluzole | 1 | 2012 | 55 | 0.030 |
Why?
|
Minority Groups | 1 | 2020 | 1223 | 0.030 |
Why?
|
Anisotropy | 1 | 2016 | 1265 | 0.030 |
Why?
|
Interleukin-1beta | 1 | 2018 | 972 | 0.030 |
Why?
|
Patient Admission | 1 | 2020 | 1380 | 0.030 |
Why?
|
Behavior, Animal | 1 | 2020 | 1881 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2017 | 713 | 0.030 |
Why?
|
Hypertrophy | 1 | 2013 | 569 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2021 | 3200 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2021 | 6171 | 0.020 |
Why?
|
Occupational Therapy | 1 | 2012 | 134 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2015 | 13102 | 0.020 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 693 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2018 | 1678 | 0.020 |
Why?
|
Seizures | 1 | 2023 | 2859 | 0.020 |
Why?
|
Neoplasms | 1 | 2019 | 21683 | 0.020 |
Why?
|
Astrocytes | 1 | 2017 | 1270 | 0.020 |
Why?
|
Vascular Diseases | 1 | 2018 | 1161 | 0.020 |
Why?
|
Regression Analysis | 1 | 2019 | 6459 | 0.020 |
Why?
|
Recurrence | 1 | 2021 | 8340 | 0.020 |
Why?
|
Arm | 1 | 2012 | 589 | 0.020 |
Why?
|
Prednisone | 1 | 2014 | 1574 | 0.020 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2014 | 518 | 0.020 |
Why?
|
Physical Therapy Modalities | 1 | 2012 | 550 | 0.020 |
Why?
|
ROC Curve | 1 | 2016 | 3527 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2013 | 1850 | 0.020 |
Why?
|
Pilot Projects | 1 | 2021 | 8324 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2023 | 15076 | 0.020 |
Why?
|
Critical Illness | 1 | 2020 | 2670 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8663 | 0.020 |
Why?
|
HIV Infections | 1 | 2012 | 16718 | 0.020 |
Why?
|
Education, Medical | 1 | 2018 | 1721 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2023 | 7880 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2018 | 4456 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2017 | 2958 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2023 | 10180 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 9959 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2014 | 1790 | 0.020 |
Why?
|
Proteomics | 1 | 2017 | 3638 | 0.010 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2012 | 1873 | 0.010 |
Why?
|
Viral Load | 1 | 2012 | 3299 | 0.010 |
Why?
|
Patient Discharge | 1 | 2016 | 3313 | 0.010 |
Why?
|
Disease Progression | 1 | 2020 | 13284 | 0.010 |
Why?
|
Survival Analysis | 1 | 2016 | 10252 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2020 | 4468 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2022 | 12261 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12245 | 0.010 |
Why?
|
Lung | 1 | 2021 | 9856 | 0.010 |
Why?
|
Clinical Competence | 1 | 2018 | 4687 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2016 | 20129 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2018 | 19229 | 0.010 |
Why?
|
Logistic Models | 1 | 2016 | 13408 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2021 | 63114 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10262 | 0.010 |
Why?
|
Neurons | 1 | 2020 | 9338 | 0.010 |
Why?
|
United States | 2 | 2020 | 69872 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2014 | 12026 | 0.010 |
Why?
|
Algorithms | 1 | 2021 | 13881 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8388 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 40075 | 0.010 |
Why?
|
Child, Preschool | 1 | 2016 | 41006 | 0.010 |
Why?
|
Concepts
(230)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(78)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_